<DOC>
	<DOCNO>NCT01427608</DOCNO>
	<brief_summary>The acute phase study monitor response combination atypical antipsychotic medication olanzapine antidepressant medication sertraline acute treatment disorder . It predict combination improve symptom psychotic depression associate metabolic side effect . Factors moderate tolerability monitor . Improvement symptom could take 4 12 week , follow period 8 week participant continue take medication stabilize remission symptom psychotic depression . The maintenance phase randomize , double-blind , placebo-controlled study olanzapine period 36 week test whether continue combination decrease risk relapse whether discontinue combination lead improvement metabolic measure . Subjects complete acute phase ask consent separately randomize maintenance phase .</brief_summary>
	<brief_title>Sustaining Remission Psychotic Depression</brief_title>
	<detailed_description>The original STOP-PD study establish combination olanzapine sertraline significantly good olanzapine alone achieve remission psychotic depression . This STOP-PD-II Sustaining Remission study aim ass long-term tolerability take combination medication efficacy prevent relapse symptom . The acute phase study monitor efficacy tolerability olanzapine sertraline combination , include investigation weight metabolic variable , age effect treatment response tolerability , association genetic polymorphism response relapse . When subject stabilize medication period 8 week invite participate randomize phase research : olanzapine placebo-controlled , mean half subject continue take olanzapine/sertraline combination half take sertraline/placebo combination , period 36 week . Symptoms side effect monitor regularly throughout phase . Randomization stratify 1:1 basis age 60 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Aged 1885 year , inclusive 2 . Diagnosis : Diagnostic Statistical ManualIV Trade Revision ( DSM IVTR ) nonbipolar major depression psychotic feature establish clinical interview research psychiatrist administration SCIDIV . 3 . Score &gt; 2 Schedule Affective Disorders ( SADS ) delusion severity item 4 . Score &gt; 1 three conviction item Delusion Assessment Scale ( DAS ) ( alter belief response reality test ) 5 . 17item HAMD score &gt; 20 1 . Current lifetime DSMIVTR history schizophrenia psychotic disorder meet current criterion brief psychotic disorder , body dysmorphic disorder obsessivecompulsive disorder 2 . Current lifetime DSMIVTR bipolar affective disorder 3 . History DSMIVTR define alcohol substance abuse dependence within past three month 4 . Dementia clinically significant cognitive impairment prior index episode depression , and/or mean score &gt; 3 26item caregiver assessment 5 . Type 1 diabetes mellitus ( define insulindependent diabetes mellitus onset age 35 , and/or diabetes mellitus complicate prior document episode ketoacidosis 6 . Acute unstable medical illness within past 3 month ; current abnormal serum free T4 ; current abnormally low vitamin B4 folic acid level ; medical condition and/or medication psychotic depressive symptom direct manifestation ; neurological disease associate extrapyramidal sign symptom ; epilepsy , person one grand mal seizure within past 12 month . 7 . The need treatment psychotropic medication sertraline , olanzapine lorazepam ; anticonvulsant medication moodstabilizing property . 8 . Current pregnancy plan become pregnant course study ; breast feeding woman infant . 9 . A documented history unable tolerate olanzapine sertraline include significant bradycardia ( heart rate &lt; 50 bpm ) , serum sodium level 129mmol/L . 10 . History nonresponse index episode psychotic depression least 6week trial least 150mg/day sertraline combine 15mg/day olanzapine 11 . Patients show ongoing improvement current episode psychotic depression treatment sertraline olanzapine 12 . Patients immediate need electroconvulsive therapy ( ECT ) ( imminent risk suicide , refuse eat , catatonic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>